Administration
行政
基本信息
- 批准号:7529421
- 负责人:
- 金额:$ 10.62万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2007
- 资助国家:美国
- 起止时间:2007-07-11 至 2012-01-31
- 项目状态:已结题
- 来源:
- 关键词:AccountingAdministratorBiometryCancer BurdenCancer CenterCancer Center Support GrantCancer ControlCatchment AreaClinical ResearchCollaborationsCommunicationComprehensive Cancer Center of Wake Forest UniversityCultured CellsDailyEffectivenessElementsEnvironmentFosteringFundingGoalsGrantGrowthIndividualLaboratoriesLeadershipMalignant NeoplasmsMissionOutpatientsPeer ReviewPhasePriceProblem SolvingPublicationsResearch InfrastructureResearch Peer ReviewResearch PersonnelResearch Project GrantsResource SharingResourcesServicesSolidStructureTalentsTumor TissueUniversitiesViral VectorVisionbasecancer research center directorcell growthcellular imagingexperienceforestimprovedinterestmemberprogramssuccess
项目摘要
This application of the Comprehensive Cancer Center of Wake Forest University (CCCWFU)
requests renewal of its Cancer Center Support Grant for Years 33 through 37.
During the current grant period, peer-reviewed annual direct cancer funding increased from $10.8 to $25.4
million, NCI funding increased from $5.1 to $12 million, and annual direct funding per member increased
from $106,000 to $233,000. Interprogrammatic publications increased from 9.1% to 11.8%, intraprogramatic
publications increased from 16.7% to 28.6%, and interdepartmental publications increased from 17.4% to
28.7%. Formal collaboration (co-investigators, consultants, or collaborators) with other Cancer Center
members is present on 68.5% of peer-reviewed research grants listed in summary II.
In the current grant cycle we have made few structural changes, and instead focused on the
execution of our scientific vision. Support is requested for four Programs: Cell Growth and
Survival, DMA Damage and Cellular Defense, Clinical Research and Cancer Control as well
as seven shared resources: Biomolecular Resource Laboratory, Cell Culture and Viral Vector,
Microarray, Cellular Imaging, Tumor Tissue, Biostatistics, and Clinical Research
Management.
During this funding period, the CCCWFU opened a new 225,000 sq.ft. outpatient cancer center, and
continued its longstanding focus and unique contributions to the cancer problems in our 7 state catchment
area. The blueprint for our next five years is embodied in this application, which provides the Center's vision
of how it can reduce the burden of cancer in our region and in the nation.
Wake Forest University(CCCWFU)综合癌症中心的这种应用
要求续签其癌症中心支持赠款33年至37年。
在当前赠款期间,经过同行评审的年度直接癌症资金从10.8美元增加到25.4美元
百万,NCI资金从5.1美元增加到1200万美元,每位成员的年度直接资金增加
从$ 106,000到$ 233,000。解释性出版物从9.1%增加到11.8%
出版物从16.7%增加到28.6%,部门间出版物从17.4%增加到
28.7%。与其他癌症中心的正式合作(共同研究人员,顾问或合作者)
摘要II中列出的同行评审研究补助金的68.5%出现。
在当前的赠款周期中,我们几乎没有结构性更改,而是专注于
执行我们的科学愿景。请求四个程序的支持:细胞增长和
生存,DMA损害和细胞防御,临床研究和癌症控制
作为七个共享资源:生物分子资源实验室,细胞培养和病毒载体,
微阵列,细胞成像,肿瘤组织,生物统计学和临床研究
管理。
在此资助期间,CCCWFU开设了一个新的225,000平方英尺。门诊癌症中心,以及
在我们的7个国家集水区中,继续其长期关注和对癌症问题的独特贡献
区域。我们接下来五年的蓝图体现在此应用程序中,这提供了中心的愿景
如何减轻我们地区和国家的癌症负担。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
FRANK M. TORTI其他文献
FRANK M. TORTI的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('FRANK M. TORTI', 18)}}的其他基金
Targeting sideroflexin 4, a mitochondrial inner membrane protein involved iniron sulfur cluster biogenesis, to enhance the efficacy of DNA-damaging drugs inovarian cancer
靶向铁弹性蛋白 4(一种参与铁硫簇生物发生的线粒体内膜蛋白),以增强 DNA 损伤药物卵巢癌的疗效
- 批准号:
10063489 - 财政年份:2019
- 资助金额:
$ 10.62万 - 项目类别:
Targeting sideroflexin 4, a mitochondrial inner membrane protein involved iniron sulfur cluster biogenesis, to enhance the efficacy of DNA-damaging drugs inovarian cancer
靶向铁弹性蛋白 4(一种参与铁硫簇生物发生的线粒体内膜蛋白),以增强 DNA 损伤药物卵巢癌的疗效
- 批准号:
10529292 - 财政年份:2019
- 资助金额:
$ 10.62万 - 项目类别:
Targeting sideroflexin 4, a mitochondrial inner membrane protein involved iniron sulfur cluster biogenesis, to enhance the efficacy of DNA-damaging drugs inovarian cancer
靶向铁弹性蛋白 4(一种参与铁硫簇生物发生的线粒体内膜蛋白),以增强 DNA 损伤药物卵巢癌的疗效
- 批准号:
9887273 - 财政年份:2019
- 资助金额:
$ 10.62万 - 项目类别:
Targeting sideroflexin 4, a mitochondrial inner membrane protein involved iniron sulfur cluster biogenesis, to enhance the efficacy of DNA-damaging drugs inovarian cancer
靶向铁弹性蛋白 4(一种参与铁硫簇生物发生的线粒体内膜蛋白),以增强 DNA 损伤药物卵巢癌的疗效
- 批准号:
10304862 - 财政年份:2019
- 资助金额:
$ 10.62万 - 项目类别: